Document is current

Article History

Received: 10 April 2024

Accepted: 2 December 2024

First Online: 24 February 2025

Competing interests

: G.E.N. has received salary support from institutional grants supported by the National Center for Translational Sciences (NCATS) and the National Institute of Digestive and Diabetes and Kidney Diseases (NIDDK), research support from the National Institute of Mental Health (NIMH), the Health Resources and Services Administration (HRSA), the Patient Centered Outcomes Research Institute (PCORI), the Barnes Jewish Hospital Foundation and the Institute for Clinical Translational Sciences, the Taylor Family Institute for Innovative Psychiatric Research, the Mallinckrodt Institute of Radiology, the McDonnell Center for Systems Neuroscience and the Center for Holistic Interdisciplinary Research in Psychedelics (CHIRP), funded by a Transcend Initiative Grant through the Here & Next Research Grants programme at Washington University. She has served as a co-investigator or principal investigator for studies funded by COMPASS Pathways, LB Pharmaceuticals, Inc., Usona Institute and Alkermes, Inc., and has received personal fees as a consultant from Carelon, Novartis and Alkermes, Inc. D.R.A. has received grant support from the NIMH (T32MH019960). E.J.L. has received grant support from Fast grants and Jansen, has consulting relationships with Pritikin ICR, Boehringer Ingelheim, Merck, IngenioRX and Prodeo and a patent pending for the use of fluvoxamine for COVID-19. L.J.C. has received research support from NIMH (T32MH019960), the Washington University in St Louis Institute for Public Health and the Center for Dissemination and Implementation (D&I) and the Center for Mental Health Services Research in the Brown School at Washington University.